Health News (Reuters)

Congo to begin Ebola vaccinations on Monday

MBANDAKA, Democratic Republic of Congo (Reuters) - Health workers in Democratic Republic of Congo will begin a vaccination campaign on Monday aimed at containing an outbreak of the deadly Ebola virus, a spokeswoman for the health ministry said.

Congo to begin Ebola vaccinations on Monday: health ministry

GOMA, Democratic Republic of Congo (Reuters) - Health workers in Democratic Republic of Congo will begin a vaccination campaign on Monday aimed at containing an outbreak of the deadly Ebola virus, a spokeswoman for the health ministry said on Sunday.

Exclusive: HCA, KKR team up for Envision bid - sources

(Reuters) - U.S. hospital operator HCA Healthcare Inc and private equity firm KKR & Co have joined forces to make an offer for U.S. physician services provider Envision Healthcare Corp , people familiar with the matter said on Friday.

Obamacare tied to earlier cancer detection in young women

(Reuters Health) - Under the Affordable Care Act (ACA) provision allowing adult children to stay on their parents' health insurance policy until age 26, young women with gynecological cancers were diagnosed and treated sooner, researchers say.

Trump proposes taking funds away from abortion providers

WASHINGTON (Reuters) - U.S. President Donald Trump on Friday issued a proposal that would effectively stop giving government funds that subsidize birth control for low-income women to Planned Parenthood and other clinics that provide abortions.

Regulators flag possible birth defect link to GSK's HIV drug

LONDON (Reuters) - U.S. and European regulators said they were assessing evidence that GlaxoSmithKline's HIV drug dolutegravir might be linked to serious birth defects, casting a shadow over a medicine that has been a key profit driver in recent years.

AstraZeneca pay report rejected by 35 percent of shareholders

LONDON (Reuters) - More than a third of AstraZeneca shareholders staged a revolt over bonuses at the pharmaceutical company on Friday, following concerns about levels of disclosures and outcomes under the company's incentive scheme.

Johnson & Johnson scraps Alzheimer's trials on safety concerns

(Reuters) - Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease.

Government proposal leaves markets gasping -- and Italians vaping

ROME (Reuters) - While Italy's 5-Star Movement and League party left financial markets gasping on Friday with promises to raise government spending dramatically, users and producers of electronic cigarettes were breathing more easily.

Congo's Ebola outbreak not yet an international emergency: WHO

GENEVA (Reuters) - An outbreak of Ebola in the Democratic Republic of Congo does not yet constitute an international public health emergency and there are strong reasons to think it can be brought under control, the World Health Organization (WHO) said on Friday.

Agile Therapeutics exploring funding options after FDA meeting

(Reuters) - Agile Therapeutics Inc said on Friday it was looking for ways to fund operations after a meeting with the U.S. health regulator raised the possibility of a new clinical trial to test its stick-on contraceptive patch, Twirla.

In Congo outbreak, Ebola vaccine faces reality tests

LONDON (Reuters) - An experimental Ebola vaccine to be deployed in an outbreak in Democratic Republic of Congo has conquered some major scientific hurdles in giving high protection, but it now faces extreme real-world tests including heat, humidity, language barriers and lack of roads.

Congo health ministry confirms 11 new cases of Ebola

KINSHASA (Reuters) - Congo has confirmed 11 new cases of Ebola in the northwest town of Bikoro, a health ministry spokeswoman said, widening an outbreak that the World Health Organization believes has already infected 44 people and killed 15.

Pages